{"id":"https://openalex.org/W2916371385","doi":"https://doi.org/10.1097/iae.0b013e318030c77c","title":"PHOTODYNAMIC THERAPY AND HIGH-DOSE INTRAVITREAL TRIAMCINOLONE TO TREAT EXUDATIVE AGE-RELATED MACULAR DEGENERATION","display_name":"PHOTODYNAMIC THERAPY AND HIGH-DOSE INTRAVITREAL TRIAMCINOLONE TO TREAT EXUDATIVE AGE-RELATED MACULAR DEGENERATION","publication_year":2007,"publication_date":"2007-03-30","ids":{"openalex":"https://openalex.org/W2916371385","doi":"https://doi.org/10.1097/iae.0b013e318030c77c","mag":"2916371385","pmid":"https://pubmed.ncbi.nlm.nih.gov/17420698"},"language":"en","primary_location":{"id":"doi:10.1097/iae.0b013e318030c77c","doi":"https://doi.org/10.1097/iae.0b013e318030c77c","is_oa":false,"landing_page_url":"https://doi.org/10.1097/iae.0b013e318030c77c","pdf_url":null,"source":{"id":"https://openalex.org/S19572933","display_name":"Retina","issn_l":"0275-004X","issn":["0275-004X","1539-2864"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retina","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073855843","display_name":"Jos\u00e9 M. Ruiz\u2010Moreno","orcid":"https://orcid.org/0000-0001-9636-0788","observed_orcids":["https://orcid.org/0000-0001-9636-0788","https://orcid.org/0000-0002-2059-0605"]},"institutions":[{"id":"https://openalex.org/I111262870","display_name":"Universitat de Miguel Hern\u00e1ndez d'Elx","ror":"https://ror.org/01azzms13","country_code":"ES","type":"education","lineage":["https://openalex.org/I111262870"]},{"id":"https://openalex.org/I4210120725","display_name":"Miranza","ror":"https://ror.org/02jcrnk02","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210120725"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"JOS\u00c9 M. RUIZ-MORENO","raw_affiliation_strings":["Department of Ophthalmology, Miguel Hern\u00e1ndez University School of Medicine, Alicante, Spain. jm.ruiz@umh.es","Alicante Institute of Ophthalmology, VISSUM, Vitreo-Retinal Unit, Alicante, Spain","Department of Ophthalmology, Miguel Hern\u00e1ndez University School of Medicine, Alicante, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Miguel Hern\u00e1ndez University School of Medicine, Alicante, Spain. jm.ruiz@umh.es","institution_ids":["https://openalex.org/I111262870"]},{"raw_affiliation_string":"Alicante Institute of Ophthalmology, VISSUM, Vitreo-Retinal Unit, Alicante, Spain","institution_ids":["https://openalex.org/I4210120725"]},{"raw_affiliation_string":"Department of Ophthalmology, Miguel Hern\u00e1ndez University School of Medicine, Alicante, Spain","institution_ids":["https://openalex.org/I111262870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110087194","display_name":"Javier Antonio Montero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120725","display_name":"Miranza","ror":"https://ror.org/02jcrnk02","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210120725"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"JAVIER A. MONTERO","raw_affiliation_strings":["Alicante Institute of Ophthalmology, VISSUM, Vitreo-Retinal Unit, Alicante, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alicante Institute of Ophthalmology, VISSUM, Vitreo-Retinal Unit, Alicante, Spain","institution_ids":["https://openalex.org/I4210120725"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058961724","display_name":"Marco A. Zarbin","orcid":"https://orcid.org/0000-0002-7811-7132","observed_orcids":["https://orcid.org/0000-0002-7811-7132"]},"institutions":[{"id":"https://openalex.org/I4402554120","display_name":"Rutgers New Jersey Medical School","ror":"https://ror.org/014ye1258","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142","https://openalex.org/I4390039302","https://openalex.org/I4402554120"]},{"id":"https://openalex.org/I4405286694","display_name":"University of Medicine and Dentistry of New Jersey","ror":"https://ror.org/02tvvmk84","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142","https://openalex.org/I4405286694"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"MARCO A. ZARBIN","raw_affiliation_strings":["Institute of Ophthalmology and Visual Science, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Ophthalmology and Visual Science, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey, USA","institution_ids":["https://openalex.org/I4402554120","https://openalex.org/I4405286694"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5073855843"],"corresponding_institution_ids":["https://openalex.org/I111262870","https://openalex.org/I4210120725"],"apc_list":null,"apc_paid":null,"fwci":6.3332,"has_fulltext":false,"cited_by_count":30,"citation_normalized_percentile":{"value":0.9661137,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"27","issue":"4","first_page":"458","last_page":"461"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10957","display_name":"Photodynamic Therapy Research Studies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/photodynamic-therapy","display_name":"photodynamic therapy","score":0.9850000143051147},{"id":"https://openalex.org/keywords/triamcinolone-acetonide","display_name":"triamcinolone acetonide","score":0.9459999799728394},{"id":"https://openalex.org/keywords/intravitreal-injection","display_name":"intravitreal injection","score":0.9620000123977661},{"id":"https://openalex.org/keywords/choroidal-neovascularization","display_name":"choroidal neovascularization","score":0.8899999856948853},{"id":"https://openalex.org/keywords/neovascular-age-related-macular-degeneration","display_name":"neovascular age-related macular degeneration","score":0.984000027179718},{"id":"https://openalex.org/keywords/best-corrected-visual-acuity","display_name":"best-corrected visual acuity","score":0.9010000228881836},{"id":"https://openalex.org/keywords/retreatment","display_name":"retreatment","score":0.6320000290870667},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5389999747276306}],"concepts":[{"id":"https://openalex.org/C2776403814","wikidata":"https://www.wikidata.org/wiki/Q27429789","display_name":"Macular degeneration","level":2,"score":0.9008233547210693},{"id":"https://openalex.org/C2781323092","wikidata":"https://www.wikidata.org/wiki/Q1428072","display_name":"Photodynamic therapy","level":2,"score":0.8428564667701721},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.785845935344696},{"id":"https://openalex.org/C2778903070","wikidata":"https://www.wikidata.org/wiki/Q2211240","display_name":"Triamcinolone acetonide","level":2,"score":0.7114089727401733},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.6402504444122314},{"id":"https://openalex.org/C2910060629","wikidata":"https://www.wikidata.org/wiki/Q27429789","display_name":"Exudative age-related macular degeneration","level":3,"score":0.5844939947128296},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.43658146262168884},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077362","descriptor_name":"Verteporfin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005122","descriptor_name":"Exudates and Transudates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005451","descriptor_name":"Fluorescein Angiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007267","descriptor_name":"Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008268","descriptor_name":"Macular Degeneration","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D008268","descriptor_name":"Macular Degeneration","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010778","descriptor_name":"Photochemotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011166","descriptor_name":"Porphyrins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014222","descriptor_name":"Triamcinolone Acetonide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014792","descriptor_name":"Visual Acuity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014822","descriptor_name":"Vitreous Body","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017319","descriptor_name":"Photosensitizing Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020256","descriptor_name":"Choroidal Neovascularization","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D020256","descriptor_name":"Choroidal Neovascularization","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/iae.0b013e318030c77c","doi":"https://doi.org/10.1097/iae.0b013e318030c77c","is_oa":false,"landing_page_url":"https://doi.org/10.1097/iae.0b013e318030c77c","pdf_url":null,"source":{"id":"https://openalex.org/S19572933","display_name":"Retina","issn_l":"0275-004X","issn":["0275-004X","1539-2864"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retina","raw_type":"journal-article"},{"id":"pmid:17420698","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17420698","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retina (Philadelphia, Pa.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1505548606","https://openalex.org/W1580014443","https://openalex.org/W1588907756","https://openalex.org/W1968078122","https://openalex.org/W1971349804","https://openalex.org/W1977790296","https://openalex.org/W1978199957","https://openalex.org/W1993743987","https://openalex.org/W2001150235","https://openalex.org/W2017080821","https://openalex.org/W2022758760","https://openalex.org/W2031878428","https://openalex.org/W2036729487","https://openalex.org/W2075677316","https://openalex.org/W2077302000","https://openalex.org/W2086964414","https://openalex.org/W2095094262","https://openalex.org/W2099838434","https://openalex.org/W2108921960","https://openalex.org/W2113050427","https://openalex.org/W2114900908","https://openalex.org/W2129949645","https://openalex.org/W2143419021","https://openalex.org/W2153824094","https://openalex.org/W2165265638"],"related_works":["https://openalex.org/W2220078099","https://openalex.org/W2030500051","https://openalex.org/W2056971931","https://openalex.org/W2044330693","https://openalex.org/W2280243110","https://openalex.org/W1588907756","https://openalex.org/W2118904015","https://openalex.org/W2158954645","https://openalex.org/W1990000332","https://openalex.org/W2031878428"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"evaluate":[2],"the":[3,28,161,192,206,227],"efficacy":[4],"of":[5,43,61,88,91,103,167,188],"photodynamic":[6],"therapy":[7],"(PDT)":[8],"and":[9,75,109,160,198,205,226],"high-dose":[10],"intravitreal":[11,59,216],"triamcinolone":[12],"acetonide":[13],"(TA)":[14],"injection":[15,60],"to":[16,71,135,153,174,218],"treat":[17,219],"choroidal":[18],"neovascularization":[19],"(CNV)":[20],"associated":[21,50],"with":[22,47,51,234],"age-related":[23],"macular":[24],"degeneration":[25],"(AMD)":[26],"at":[27],"2-year":[29],"follow-up.":[30],"METHODS:":[31],"In":[32],"this":[33],"prospective,":[34],"consecutive,":[35],"comparative,":[36],"nonrandomized,":[37],"interventional":[38],"case":[39],"series,":[40],"30":[41,44],"eyes":[42,68,90],"consecutive":[45],"patients":[46,93],"subfoveal":[48],"CNV":[49],"AMD":[52],"were":[53,69,112],"treated":[54,79,94],"by":[55,58,81,95],"PDT":[56,82,96,110,189],"followed":[57],"19.4":[62],"+/-":[63,129,148,169],"2.1":[64],"mg":[65],"TA.":[66],"Fifteen":[67],"naive":[70],"treatment":[72],"(group":[73,84],"1),":[74],"15":[76,89,92],"had":[77],"been":[78],"previously":[80],"alone":[83,97],"2).":[85],"A":[86],"group":[87,124,142,163,201,203],"served":[98],"as":[99],"controls.":[100,236],"The":[101,185],"number":[102,187],"Snellen":[104,131,137,155,176],"lines":[105,171],"gained":[106],"or":[107],"lost":[108,144,164],"sessions":[111,190],"evaluated.":[113],"RESULTS:":[114],"Best-corrected":[115],"visual":[116],"acuity":[117],"(BCVA)":[118],"did":[119],"not":[120],"change":[121],"significantly":[122],"in":[123],"1":[125],"from":[126],"baseline":[127],"(0.0":[128],"3.4":[130,170],"line;":[132],"range,":[133],"-5":[134],"9":[136],"lines;":[138],"P":[139],"=":[140,158,179],"0.81);":[141],"2":[143,175],"an":[145,165],"average":[146,166,186],"-0.6":[147],"2.5":[149],"line":[150],"(range,":[151,172],"-7":[152],"3":[154],"lines)":[156,177],"(P":[157,178],"0.41),":[159],"control":[162,207],"-2.2":[168],"-8":[173],"0.03,":[180],"Wilcoxon":[181],"signed":[182],"rank":[183],"test).":[184],"during":[191],"24-month":[193],"follow-up":[194],"was":[195,224,231],"1.9,":[196],"1.2,":[197],"3.9":[199],"for":[200,229],"1,":[202],"2,":[204],"group,":[208],"respectively.":[209],"CONCLUSION:":[210],"Two":[211],"years":[212],"after":[213],"combined":[214],"PDT/high-dose":[215],"TA":[217],"AMD-associated":[220],"CNV,":[221],"final":[222],"BCVA":[223],"stable,":[225],"need":[228],"retreatment":[230],"reduced":[232],"compared":[233],"historical":[235]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2019-03-02T00:00:00"}